Lifeboat Foundation

According to ScienceDaily:

The British-American biotech company Acambis reports the successful conclusion of Phase I trials of the universal flu vaccine in humans. The universal influenza vaccine has been pioneered by researchers from VIB and Ghent University. This vaccine is intended to provide protection against all ‘A’ strains of the virus that causes human influenza, including pandemic strains. Therefore, this vaccine will not need to be renewed annually.

What would make this new vaccine different from the ones already available is that it would target M2e, a conserved region of influenza “A” strains. Since that part doesn’t constantly mutate and about 2/3 of seasonal epidemics and all pandemics are due to type “A” strains, it could be a very efficient weapon against repeats of the “Spanish Flu” (1918−1919) that killed at least 50 million people worldwide. Only the future will tell if phase II and III trials are successful.

You can learn more about the Lifeboat Foundation BioShield program here.

Reposted from Next Big Future which was advancednano.

A 582,970 base pair sequence of DNA has been synthesized.

It’s the first time a genome the size of a bacterium has chemically been synthesized that’s about 20 times longer than [any DNA molecule] synthesized before.

This is a huge increase in capability. It has broad implications for DNA nanotechnology and synthetic biology.

Continue reading “On the brink of Synthetic Life: DNA synthesis has increased twenty times to full bacteria size” »

Planning for the first Lifeboat Foundation conference has begun. This FREE conference will be held in Second Life to keep costs down and ensure that you won’t have to worry about missing work or school.

While an exact date has not yet been set, we intend to offer you an exciting line up of speakers on a day in the late spring or early summer of 2008.

Several members of Lifeboat’s Scientific Advisory Board (SAB) have already expressed interest in presenting. However, potential speakers need not be Lifeboat Foundation members.

If you’re interested in speaking, want to help, or you just want to learn more, please contact me at matt@lifeboat.com.

I’ve been taking a look at an “international civil society organization” called the ETC Group. The “ETC” group is also known as the “Action Group on Erosion, Technology and Concentration”. To be honest, I can’t figure them out. Here is a summary:

“ETC Group is an international civil society organization based in Canada. We are dedicated to the conservation and sustainable advancement of cultural and ecological diversity and human rights. ETC Group supports socially responsible development of technologies useful to the poor and marginalized and we address international governance issues affecting the international community. We also monitor the ownership and control of technologies and the consolidation of corporate power.”

So they look like a somewhat standard leftist environmentalist technology oversight group. Alright.

Continue reading “ETC Group: Action Group on Erosion, Technology and Concentration” »

Robert Freitas, Jr., Lifeboat Foundation Fellow and head of the Lifeboat Foundation’s Nanomedicine Division has won the 2007 Foresight Institute Feynman Prize in Communication.

Dr. Pearl Chin, President of the Foresight Nanotech Institute, said Freitas received the award for “pioneering the study and communication of the benefits to be obtained from an advanced nanomedicine that will be made possible by molecular manufacturing [and for having] worked to develop and communicate a path from our current technology base to a future technology base that will enable advanced nanomedicine.”

Prior to his Feynman Prize win Robert shared the Lifeboat Foundation’s 2006 Guardian Award with technology legend Bill Joy. Freitas and Joy shared the Guardian award for their many years of work on mitigating risks posed by advanced technologies.

The European Commission is funding a 2-year, $312,000 study on the safety and ethical aspects of synthetic biology. From the introduction part of the site:

We will pursue our objectives by means of a fact-finding mission, contribution to the European “inaugural” Conference on Synthetic Biology in Zurich (SB 3.0), an open e-forum and an international workshop. The foreseen impact of our project will be no less than to stimulate a European debate on these issues at an early stage. Past experiences, especially in the field of GM-crops, have shown the importance of an early bio-safety and ethics debate. The community recognized this need, but up to now discussions are fragmentary. Our project aims to stimulate a European debate in a proactive way. That way we will contribute to the European synthetic biology community, supplementing genuine biosafety and bioethics aspects.

Looks like a great start on addressing a very important area of concern. For a blog post of mine that goes into a bit more detail on the issue of synthetic biology and its risks, see here.

Five evolutionary stages of pathogen progression from animals to human transmission have been identified A proposed monitoring system of viral chatter has been proposed to provide warning of new diseases before they spread to humans.

In 1999, Wolfe began field work in the jungles of Cameroon to track “viral chatter,” or the regular transmission of diseases from animals to people, usually without further spread among humans. By monitoring the habits and the blood pathologies of bushmeat hunters and their kills, Wolfe and his team have identified at least three previously unknown retroviruses from the same family as HIV, as well as promoted safe practices for handling animals and animal carcasses.

“The Cameroon project demonstrated that it’s possible to collect information on viral transmission under very difficult circumstances from these highly exposed people,” Wolfe said.

With Cameroon as a prototype and a $2.5 million National Institutes of Health Pioneer Award as seed money, Wolfe has gone on to create a network of virus-discovery projects that monitor hunters, butchers, and wildlife trade and zoo workers in some of the world’s most remote viral hotspots. The network of a dozen sites in China, the Democratic Republic of Congo, Malaysia, Laos, Madagascar and Paraguay include source locations for such emerging diseases as SARS, avian flu, Nipah, Ebola and monkeypox.

Continue reading “Researchers Endorse Global Early Warning System to Prevent Pandemics” »

DARPA (the defense advanced research projects agency) is the R&D arm of he US military for far-reaching future technology. What most people do not realize is how much revolutionary medical technology comes out of this agency’s military R&D programs. For those in need of background, you can read about the Army & DARPA’s future soldier Landwarrior program and its medtech offshoots as well as why DARPA does medical research and development that industry won’t. Fear of these future military technologies runs high with a push towards neural activation as a weapon, direct brain-computer interfaces, and drones. However, the new program has enormous potential for revolutionary medical progess as well.

It has been said technology is neutral, it is the application that is either good or evil. (It is worth a side-track to read a discussion on this concept)

The Areas of Focus for DARPA in 2007 and Forward Are:

1. Chip-Scale Atomic Clock
2. Global War on TerrorismUnmanned Air Vehicles
3. Militarization of Space
4. Supercomputer Systems
5. Biological Warfare Defense
6. Prosthetics
7. Quantum Information Science
8. Newton’s Laws for Biology
9. Low-Cost Titanium
10. Alternative Energy
11. High Energy Liquid Laser Area Defense System

the potential for the destructive use of these technologies is obvious, for a a complete review of these projects and the beneficial medical applications of each visit docinthemachine.com